Haemonetics Corporation reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was USD 318.18 million compared to USD 297.49 million a year ago. Net income was USD 24.91 million compared to USD 33.2 million a year ago. Basic earnings per share from continuing operations was USD 0.49 compared to USD 0.65 a year ago. Diluted earnings per share from continuing operations was USD 0.48 compared to USD 0.64 a year ago.
For the six months, sales was USD 629.52 million compared to USD 558.94 million a year ago. Net income was USD 65.95 million compared to USD 53.07 million a year ago. Basic earnings per share from continuing operations was USD 1.3 compared to USD 1.04 a year ago. Diluted earnings per share from continuing operations was USD 1.28 compared to USD 1.03 a year ago.